Patient-Driven/Youth Advisory Board
Resource updated 02/27/2024
Resource updated 02/27/2024
Rapid has developed into a core feature of the Dorothy Mann Center HIV care continuum, assuring immediate linkage to expert HIV services, immediate initiation of therapy, and rapid viral suppression. Benefits are present for youth prevention services. Rapid access models are feasible and beneficial for youth HIV care and prevention.
Resource (Conference Presentation) updated 09/14/2023
A clinic-based substance abuse screening and treatment program is described. Using the Screening, Brief Intervention, and Referral to Treatment model, this provides annual proactive screening of alcohol/drug use, with a brief provider response and a follow-up motivational interviewing brief intervention, with treatment provided by an embedded provider.
Resource (Conference Presentation) updated 09/14/2023
Using data to identify disability-related needs of RWHAP provider agencies and clients to assess outcomes along the HIV Care Continuum, the New York HIV Planning Council developed with recipient support recommendations to better accommodate people with HIV with disabilities living in the New York EMA to improve service delivery, engagement, and viral suppression.
Resource (Conference Presentation) updated 09/14/2023
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
This interactive workshop will share Virginia's experiences and lessons learned from the Virginia Consumer Advisory Committee (VACAC). The workshop will provide perspective on effectively engaging consumers in ending the HIV/AIDS epidemic. The session will highlight VACAC's structure and how it interacts with consumers, the Virginia Department of Health, and service providers.
Resource (Conference Presentation) updated 09/14/2023
This session will explore the continuum of meaningful involvement among persons with HIV at the community, regional, and national levels. A panel of community stakeholders will share experiences participating in community forums, boards, and other advocacy opportunities.
Resource (Conference Presentation) updated 09/14/2023
This session will share how three health departments created and cultivated a partnership that resulted in changes to Part A services administration and provision in the Washington, D.C., EMA.
Resource (Conference Presentation) updated 09/14/2023
Cuaderno de trabajo sobre cómo establecer y operar una junta asesora para los consumidores (CAB, siglas en inglés), relacionada con las operaciones de CAB para los programas dirigidos a las mujeres, bebés, niños y jóvenes de la Parte D (Título IV).
Resource updated 09/19/2023
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023
People with HIV can experience disabling comorbidities that limit their ability to access HIV services, resulting in potential discrimination and negative health outcomes. This session will include a summary of federal protections for people with disabilities and how providers can address barriers to care caused by comorbidities.
Resource (Conference Presentation) updated 09/14/2023
Rapid initiation of antiretroviral therapy (ART) after diagnosis can increase the number of patients arriving for appointments, shorten time to viral suppression, and promote health equity. The presenters share key lessons learned through the implementation process at a large HIV clinic in the South with the theme of partnerships.
Resource (Conference Presentation) updated 09/14/2023
In December 2016 CrescentCare began linking individuals newly diagnosed with within 72-hours through the CrescentCare START Initiative. We compared linkage and viral suppression between those under and over 24 years old. We found similar successful outcomes for both age cohorts in our intervention.
Resource (Conference Presentation) updated 09/14/2023
Implementation of rapid antiretroviral therapy (ART) initiation is beset with clinical and process challenges. Three clinical providers will share their lessons learned from developing a program and delivering care in various care settings (pediatric, adult, and walk-in clinic).
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 12/11/2023
Rapid antiretroviral treatment (ART) initiation in the United States remained 'investigational' until the update in the Department of Health and Human Services guidelines (December 18, 2019). Centers for AIDS Research (CFARs) in D.C., the San Francisco Bay area, and Baltimore will share how they are working with their health departments and implementing partners, including Ryan White-funded clinics to address rapid ART implementation strategies.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 12/11/2023
Timely antiretroviral treatment (ART) initiation, linkage, and retention in care are critical keys for the optimal outcomes in patients with HIV infection. Implementing an open access process for medical, mental, and intensive case management care gives patients the ability to better achieve medication adherence and viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
North Carolina's HIV/STD/Viral Hepatitis Unit, along with Western North Carolina Community Health Services and Carolina Family Health Center -- two federally qualified health centers (FQHCs) -- has initiated a pilot rapid antiretroviral treatment (ART) program utilizing carryover funds and a streamlined HIV Medication Assistance Program application process. Preliminary data will be shared on the success of the pilot program.
Resource (Conference Presentation) updated 09/14/2023
This presentation will review findings and lessons learned after implementing a pilot rapid antiretroviral therapy (ART) initiation protocol into an existing federally qualified health center (FQHC) setting. Presenters will describe the processes used for rapid linkage, benefits eligibility assessment, and provider appointment with ART initiation.
Resource (Conference Presentation) updated 09/14/2023